A comparative study of PRAME expression in sebaceous carcinoma and basal cell carcinoma.
作者信息
Doost Mohammad Saffari, Ortega-Springall Maria Fernanda, Meyer Summer N, Love Nick R, Konia Thomas, Fung Maxwell A, Kiuru Maija
机构信息
Department of Dermatology, University of California Davis School of Medicine, 3301 C Street, Suite 1400, Sacramento, CA 95816, USA.
Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA.
出版信息
JEADV Clin Pract. 2024 Jun;3(2):738-741. doi: 10.1002/jvc2.356. Epub 2024 Jan 9.
Abstract
摘要
相似文献
1
A comparative study of PRAME expression in sebaceous carcinoma and basal cell carcinoma.皮脂腺癌和基底细胞癌中PRAME表达的比较研究
JEADV Clin Pract. 2024 Jun;3(2):738-741. doi: 10.1002/jvc2.356. Epub 2024 Jan 9.
2
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.PRAME 在皮脂病变、皮肤癌和附属结构中的免疫染色表达。
Pathology. 2022 Oct;54(6):721-728. doi: 10.1016/j.pathol.2022.03.003. Epub 2022 May 26.
3
Androgen Receptor Immunohistochemistry is Superior to PRAME for the Differentiation of Sebaceous Carcinoma From Primary Cutaneous Basaloid Mimics.雄激素受体免疫组化优于 PRAME 用于鉴别原发性皮肤基底细胞样肿瘤样癌与皮脂腺癌。
Am J Dermatopathol. 2024 Apr 1;46(4):195-203. doi: 10.1097/DAD.0000000000002496. Epub 2023 Dec 13.
4
PRAME Staining of Adnexal Lesions and Common Skin Cancer Types: Biomarker with Potential Diagnostic Utility.附件病变和常见皮肤癌类型的PRAME染色：具有潜在诊断效用的生物标志物
Dermatopathology (Basel). 2024 Dec 12;11(4):364-373. doi: 10.3390/dermatopathology11040039.
5
Periocular Sebaceous Carcinoma: A Case Audit from the National Specialist Ophthalmic Pathology Service in Liverpool from 2009 to 2022 to Assess the Diagnostic Utility of PRAME Expression.眼周皮脂腺癌：来自利物浦国家专业眼科病理服务中心2009年至2022年的病例审核，以评估PRAME表达的诊断效用。
Ocul Oncol Pathol. 2024 Apr;10(1):1-8. doi: 10.1159/000535169. Epub 2023 Dec 10.
6
PRAME Immuno-Expression in Cutaneous Sebaceous Carcinoma: A Single Institutional Experience.PRAME在皮肤皮脂腺癌中的免疫表达：单机构经验
J Clin Med. 2022 Nov 24;11(23):6936. doi: 10.3390/jcm11236936.
7
Comparison of adipophilin and recently introduced PReferentially expressed Antigen in MElanoma immunohistochemistry in the assessment of sebaceous neoplasms: A pilot study.在皮脂腺肿瘤评估中比较脂联素和最近引入的黑色素瘤优先表达抗原免疫组化：一项初步研究。
J Cutan Pathol. 2021 Oct;48(10):1252-1261. doi: 10.1111/cup.14043. Epub 2021 May 17.
8
Preferentially expressed antigen in melanoma expression in nonmelanoma skin cancers and melanocytes in surrounding skin.黑色素瘤中优先表达的抗原在非黑色素瘤皮肤癌及周围皮肤的黑色素细胞中的表达。
J Cutan Pathol. 2021 Sep;48(9):1150-1155. doi: 10.1111/cup.14012. Epub 2021 Mar 28.
9
Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma.直接靶向PRAME或通过抑制EZH2克服维甲酸耐药性，是一种治疗皮肤鳞状细胞癌的新疗法。
Mol Oncol. 2025 May;19(5):1471-1492. doi: 10.1002/1878-0261.13820. Epub 2025 Mar 18.
10
PRAME expression and its prognostic significance in invasive breast carcinoma.PRAME在浸润性乳腺癌中的表达及其预后意义。
Pathol Res Pract. 2024 Feb;254:155096. doi: 10.1016/j.prp.2024.155096. Epub 2024 Jan 4.
本文引用的文献
1
PRAME Immuno-Expression in Cutaneous Sebaceous Carcinoma: A Single Institutional Experience.PRAME在皮肤皮脂腺癌中的免疫表达：单机构经验
J Clin Med. 2022 Nov 24;11(23):6936. doi: 10.3390/jcm11236936.
2
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.PRAME 在皮脂病变、皮肤癌和附属结构中的免疫染色表达。
Pathology. 2022 Oct;54(6):721-728. doi: 10.1016/j.pathol.2022.03.003. Epub 2022 May 26.
3
Comparison of adipophilin and recently introduced PReferentially expressed Antigen in MElanoma immunohistochemistry in the assessment of sebaceous neoplasms: A pilot study.在皮脂腺肿瘤评估中比较脂联素和最近引入的黑色素瘤优先表达抗原免疫组化：一项初步研究。
J Cutan Pathol. 2021 Oct;48(10):1252-1261. doi: 10.1111/cup.14043. Epub 2021 May 17.
4
PRAME Expression in Melanocytic Tumors.黑色素细胞肿瘤中的 PRAME 表达。
Am J Surg Pathol. 2018 Nov;42(11):1456-1465. doi: 10.1097/PAS.0000000000001134.
5
Sebaceous gland carcinoma. Review of 40 cases.皮脂腺癌。40例病例回顾。
Arch Ophthalmol. 1984 Feb;102(2):245-9. doi: 10.1001/archopht.1984.01040030195025.
Zotero 插件